• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用振动网孔雾化器、射流雾化器和软雾吸入器递送抗结核噬菌体 D29。

Anti-Tuberculosis Bacteriophage D29 Delivery with a Vibrating Mesh Nebulizer, Jet Nebulizer, and Soft Mist Inhaler.

机构信息

Department of Mechanical Engineering, University of Alberta, Edmonton, AB, Canada.

Advanced Drug Delivery Group, Faculty of Pharmacy, University of Sydney, Sydney, Australia.

出版信息

Pharm Res. 2017 Oct;34(10):2084-2096. doi: 10.1007/s11095-017-2213-4. Epub 2017 Jun 23.

DOI:10.1007/s11095-017-2213-4
PMID:28646325
Abstract

PURPOSE

To compare titer reduction and delivery rate of active anti-tuberculosis bacteriophage (phage) D29 with three inhalation devices.

METHODS

Phage D29 lysate was amplified to a titer of 11.8 ± 0.3 log(pfu/mL) and diluted 1:100 in isotonic saline. Filters captured the aerosolized saline D29 preparation emitted from three types of inhalation devices: 1) vibrating mesh nebulizer; 2) jet nebulizer; 3) soft mist inhaler. Full-plate plaque assays, performed in triplicate at multiple dilution levels with the surrogate host Mycobacterium smegmatis, were used to quantify phage titer.

RESULTS

Respective titer reductions for the vibrating mesh nebulizer, jet nebulizer, and soft mist inhaler were 0.4 ± 0.1, 3.7 ± 0.1, and 0.6 ± 0.3 log(pfu/mL). Active phage delivery rate was significantly greater (p < 0.01) for the vibrating mesh nebulizer (3.3x10 ± 0.8x10 pfu/min) than for the jet nebulizer (5.4x10 ± 1.3x10 pfu/min). The soft mist inhaler delivered 4.6x10 ± 2.0x10 pfu per 11.6 ± 1.6 μL ex-actuator dose.

CONCLUSIONS

Delivering active phage requires a prudent choice of inhalation device. The jet nebulizer was not a good choice for aerosolizing phage D29 under the tested conditions, due to substantial titer reduction likely occurring during droplet production. The vibrating mesh nebulizer is recommended for animal inhalation studies requiring large amounts of D29 aerosol, whereas the soft mist inhaler may be useful for self-administration of D29 aerosol.

摘要

目的

比较活性抗结核噬菌体(噬菌体)D29 在三种吸入装置中的滴度降低和输送率。

方法

噬菌体 D29 裂解物扩增至 11.8 ± 0.3 log(pfu/mL),并用等渗盐水稀释 1:100。过滤器捕获从三种类型的吸入装置中雾化的生理盐水 D29 制剂:1)振动网雾化器;2)射流雾化器;3)软雾吸入器。使用替代宿主耻垢分枝杆菌进行三次稀释水平的全板菌斑测定,以定量噬菌体滴度。

结果

振动网雾化器、射流雾化器和软雾吸入器的相应滴度降低分别为 0.4 ± 0.1、3.7 ± 0.1 和 0.6 ± 0.3 log(pfu/mL)。活性噬菌体输送率显著更高(p < 0.01),振动网雾化器为 3.3x10 ± 0.8x10 pfu/min,而射流雾化器为 5.4x10 ± 1.3x10 pfu/min。软雾吸入器每 11.6 ± 1.6 μL 执行器剂量输送 4.6x10 ± 2.0x10 pfu。

结论

输送活性噬菌体需要谨慎选择吸入装置。在测试条件下,射流雾化器不是雾化噬菌体 D29 的好选择,因为在液滴生成过程中可能会发生大量滴度降低。振动网雾化器推荐用于需要大量 D29 气溶胶的动物吸入研究,而软雾吸入器可能适用于 D29 气溶胶的自我给药。

相似文献

1
Anti-Tuberculosis Bacteriophage D29 Delivery with a Vibrating Mesh Nebulizer, Jet Nebulizer, and Soft Mist Inhaler.利用振动网孔雾化器、射流雾化器和软雾吸入器递送抗结核噬菌体 D29。
Pharm Res. 2017 Oct;34(10):2084-2096. doi: 10.1007/s11095-017-2213-4. Epub 2017 Jun 23.
2
Physicochemical aspects and efficiency of albuterol nebulization: comparison of three aerosol types in an in vitro pediatric model.沙丁胺醇雾化的物理化学特性及效率:体外儿科模型中三种气雾剂类型的比较
Respir Care. 2015 Jan;60(1):38-46. doi: 10.4187/respcare.02490. Epub 2014 Dec 16.
3
Effect of Aerosol Devices and Administration Techniques on Drug Delivery in a Simulated Spontaneously Breathing Pediatric Tracheostomy Model.雾化装置和给药技术对模拟自主呼吸小儿气管造口模型中药物递送的影响。
Respir Care. 2015 Jul;60(7):1026-32. doi: 10.4187/respcare.03592. Epub 2015 Mar 3.
4
SPECT-CT Comparison of Lung Deposition using a System combining a Vibrating-mesh Nebulizer with a Valved Holding Chamber and a Conventional Jet Nebulizer: a Randomized Cross-over Study.使用振动网式雾化器与带阀储雾罐相结合的系统和传统喷射雾化器进行肺部沉积的SPECT-CT比较:一项随机交叉研究。
Pharm Res. 2017 Feb;34(2):290-300. doi: 10.1007/s11095-016-2061-7. Epub 2016 Nov 7.
5
Comparison of Vibrating Mesh, Jet, and Breath-Enhanced Nebulizers During Mechanical Ventilation.振动网孔、射流和呼吸增强型雾化器在机械通气中的比较。
Respir Care. 2020 Oct;65(10):1419-1426. doi: 10.4187/respcare.07639. Epub 2020 Jul 21.
6
Enhanced Aerosol Delivery During High-Flow Nasal Cannula Therapy.高流量鼻导管治疗时增强的气溶胶输送。
Respir Care. 2023 Sep;68(9):1221-1228. doi: 10.4187/respcare.10644. Epub 2023 May 30.
7
Particle Dynamics and Bioaerosol Viability of Aerosolized Bacillus Calmette-Guérin Vaccine Using Jet and Vibrating Mesh Clinical Nebulizers.利用射流和振动网式临床雾化器雾化卡介苗的颗粒动力学和生物气溶胶存活情况。
J Aerosol Med Pulm Drug Deliv. 2022 Jan;35(1):50-56. doi: 10.1089/jamp.2021.0030. Epub 2021 Oct 6.
8
Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.使用空气喷射雾化器和具有大网孔的新型微泵装置递送的脂质体的物理稳定性和气溶胶特性。
Int J Pharm. 2007 Apr 4;334(1-2):62-70. doi: 10.1016/j.ijpharm.2006.10.022. Epub 2006 Oct 21.
9
Nebulization effects on structural stability of bacteriophage PEV 44.雾化对噬菌体 PEV44 结构稳定性的影响。
Eur J Pharm Biopharm. 2018 Apr;125:124-130. doi: 10.1016/j.ejpb.2018.01.010. Epub 2018 Jan 17.
10
In vitro comparison of five nebulizers during noninvasive ventilation: analysis of inhaled and lost doses.无创通气期间五种雾化器的体外比较:吸入剂量与损失剂量分析
J Aerosol Med Pulm Drug Deliv. 2014 Dec;27(6):430-40. doi: 10.1089/jamp.2013.1070.

引用本文的文献

1
Latest Advances in Inhalable Dry Powder Bacteriophage Therapy for Pulmonary Infections.吸入性干粉噬菌体治疗肺部感染的最新进展
Pharmaceutics. 2025 Aug 20;17(8):1077. doi: 10.3390/pharmaceutics17081077.
2
Inhalable Nanotechnology-Based Drug Delivery Systems for the Treatment of Inflammatory Lung Diseases.用于治疗炎症性肺部疾病的基于纳米技术的可吸入药物递送系统。
Pharmaceutics. 2025 Jul 9;17(7):893. doi: 10.3390/pharmaceutics17070893.
3
Bacteriophage therapy for multidrug-resistant infections: current technologies and therapeutic approaches.

本文引用的文献

1
Phage Inhibit Pathogen Dissemination by Targeting Bacterial Migrants in a Chronic Infection Model.在慢性感染模型中,噬菌体通过靶向细菌迁移体抑制病原体传播。
mBio. 2017 Apr 4;8(2):e00240-17. doi: 10.1128/mBio.00240-17.
2
Production of Inhalation Phage Powders Using Spray Freeze Drying and Spray Drying Techniques for Treatment of Respiratory Infections.采用喷雾冷冻干燥和喷雾干燥技术制备吸入性噬菌体粉末用于治疗呼吸道感染
Pharm Res. 2016 Jun;33(6):1486-96. doi: 10.1007/s11095-016-1892-6. Epub 2016 Feb 29.
3
Inhalation Study of Mycobacteriophage D29 Aerosol for Mice by Endotracheal Route and Nose-Only Exposure.
用于多重耐药感染的噬菌体疗法:当前技术与治疗方法
J Clin Invest. 2025 Mar 3;135(5):e187996. doi: 10.1172/JCI187996.
4
Phage therapeutic delivery methods and clinical trials for combating clinically relevant pathogens.用于对抗临床相关病原体的噬菌体治疗递送方法及临床试验。
Ther Deliv. 2025 Mar;16(3):247-269. doi: 10.1080/20415990.2024.2426824. Epub 2024 Nov 15.
5
Phage Therapy Against Antibiotic-Resistant and Multidrug-Resistant Infections Involving Nonhealing Wounds and Prosthetic Joint Infections Associated With Biofilms: A Mini-Review.针对涉及不愈合伤口及与生物膜相关的人工关节感染的抗生素耐药和多重耐药感染的噬菌体疗法:一篇综述。
Can J Infect Dis Med Microbiol. 2024 Nov 7;2024:6252415. doi: 10.1155/2024/6252415. eCollection 2024.
6
Respiratory Delivery of GG by Vibrating-Mesh and Jet Nebulisation.通过振动网式雾化器和喷射雾化器进行GG的呼吸道给药。
Pharmaceutics. 2024 Oct 14;16(10):1326. doi: 10.3390/pharmaceutics16101326.
7
Mycobacteriophages and Their Applications.分枝杆菌噬菌体及其应用
Antibiotics (Basel). 2024 Sep 27;13(10):926. doi: 10.3390/antibiotics13100926.
8
Antibacterial efficacy of mycobacteriophages against virulent Mycobacterium tuberculosis.噬菌体对毒力结核分枝杆菌的抗菌效果。
BMC Microbiol. 2024 Sep 4;24(1):320. doi: 10.1186/s12866-024-03474-3.
9
Bacteriophages and Their Clinical Applications.噬菌体及其临床应用。
Viruses. 2024 Jun 29;16(7):1051. doi: 10.3390/v16071051.
10
Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study.100 例连续病例的个体化噬菌体治疗结果:一项多中心、多国、回顾性观察研究。
Nat Microbiol. 2024 Jun;9(6):1434-1453. doi: 10.1038/s41564-024-01705-x. Epub 2024 Jun 4.
经气管内途径和仅经鼻暴露对小鼠进行分枝杆菌噬菌体D29气溶胶吸入研究。
J Aerosol Med Pulm Drug Deliv. 2016 Oct;29(5):393-405. doi: 10.1089/jamp.2015.1233. Epub 2016 Jan 8.
4
Phage therapy of pulmonary infections.肺部感染的噬菌体疗法。
Bacteriophage. 2015 Apr 18;5(1):e1020260. doi: 10.1080/21597081.2015.1020260. eCollection 2015 Jan-Mar.
5
Use of Extrathoracic Deposition Models for Patient-Specific Dose Estimation during Inhaler Design.在吸入器设计过程中使用胸外沉积模型进行患者特异性剂量估计。
Curr Pharm Des. 2015;21(27):3984-92. doi: 10.2174/1381612821666150820110713.
6
The antibiotic resistance crisis: part 1: causes and threats.抗生素耐药性危机:第一部分:成因与威胁。
P T. 2015 Apr;40(4):277-83.
7
Bacteriophage Delivery by Nebulization and Efficacy Against Phenotypically Diverse Pseudomonas aeruginosa from Cystic Fibrosis Patients.通过雾化递送噬菌体及其对来自囊性纤维化患者的表型多样的铜绿假单胞菌的疗效
J Aerosol Med Pulm Drug Deliv. 2015 Oct;28(5):353-60. doi: 10.1089/jamp.2014.1172. Epub 2015 Feb 25.
8
Physicochemical aspects and efficiency of albuterol nebulization: comparison of three aerosol types in an in vitro pediatric model.沙丁胺醇雾化的物理化学特性及效率:体外儿科模型中三种气雾剂类型的比较
Respir Care. 2015 Jan;60(1):38-46. doi: 10.4187/respcare.02490. Epub 2014 Dec 16.
9
Taking bacteriophage therapy seriously: a moral argument.认真对待噬菌体疗法:一种道德论证。
Biomed Res Int. 2014;2014:621316. doi: 10.1155/2014/621316. Epub 2014 Apr 29.
10
Aerosol phage therapy efficacy in Burkholderia cepacia complex respiratory infections.气溶胶噬菌体疗法在洋葱伯克霍尔德菌复合体呼吸道感染中的疗效
Antimicrob Agents Chemother. 2014 Jul;58(7):4005-13. doi: 10.1128/AAC.02388-13. Epub 2014 May 5.